Revisiting retinal and macular degeneration in the genomics era.

Genomic advances have identified causal genes and variants, paving the way for targeted therapies for retinal and macular degeneration affecting millions globally.

• Why it matters: Retinal and macular degeneration are leading causes of irreversible vision loss, yet effective treatments are limited due to complex genetic and clinical variability, hindering progress.
• What they did: Researchers utilized next-generation sequencing, computational tools, human models, and genetic manipulation to uncover genetic factors and gene networks involved in these degenerations.
• The result: These insights enable the development of therapies aimed at slowing or reversing vision loss, offering hope for personalized treatment approaches in the future.